By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084



Company News
Advaxis, Inc. Presents Lm-LLO Cancer Immunotherapy Data at the 2015 AACR Meeting 4/21/2015 4:42:03 PM
Advaxis, Inc. Included Among "25 Top Immunotherapy Companies" In Newly Launched Loncar Cancer Immunotherapy Index (LCINDX) 4/10/2015 8:42:44 AM
Advaxis, Inc. And Merck & Co. (MRK) Announce Initiation Of Enrollment In The Phase I/II Study Of ADXS-PSA In Combination With Anti-PD-1 Therapy, KEYTRUDA (Pembrolizumab), For The Treatment Of Advanced Prostate Cancer 4/8/2015 7:15:53 AM
Advaxis, Inc. And RTOG Foundation To Collaborate On Pivotal Phase 2/3 Clinical Trial Of ADXS-HPV In Anal Cancer 4/6/2015 6:53:35 AM
Advaxis, Inc. To Present At The Jefferies Immuno-Oncology Summit 3/30/2015 6:35:33 AM
Advaxis, Inc.'s Lm-LLO Immunotherapy Platform To Be Featured In Three Poster Presentations At The 2015 American Association for Cancer Research Annual Meeting 3/19/2015 7:43:34 AM
Advaxis, Inc. Announces First Patient Treated In Phase 1/2 Dose-Escalation Study Of ADXS-HPV For Recurrent Cervical Cancer 3/19/2015 7:18:48 AM
Advaxis, Inc. Presents Preliminary Data From A Phase I/II Trial Of ADXS-HPV In HPV-Associated Anal Cancer In Combination With Chemoradiation Showing Complete Response And No Recurrences To Date In All Treated Patientsa 3/16/2015 7:15:21 AM
Gynecologic Oncology Group Commences Enrollment In Stage 2 Of GOG-0265 Clinical Trial 3/11/2015 7:29:15 AM
Advaxis, Inc. To Present At The 27th Annual ROTH Conference 3/5/2015 7:55:59 AM